NCT05532254View on ClinicalTrials.gov

Bioequivalence Study of Aripiprazole in Healthy Adult Subjects Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

February 14, 2021

Primary Completion Date

March 11, 2021

Study Completion Date

March 11, 2021

Conditions
Healthy Subjects
Interventions
DRUG

Aripiprazole 10 mg tablet

an immediate-release tablet containing 10 mg Aripiprazole

DRUG

Abilify® 10 mg tablet

an immediate-release tablet containing 10 mg Aripiprazole

Trial Locations (1)

11835

Future Research Center (FRC), Cairo

All Listed Sponsors
lead

Future University in Egypt

OTHER

NCT05532254 - Bioequivalence Study of Aripiprazole in Healthy Adult Subjects Under Fasting Condition | Biotech Hunter | Biotech Hunter